fosinopril has been researched along with atenolol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, MS; Chen, CH; Chou, P; Hsu, TL; Lin, SJ; Siu, CO; Ting, CT; Wang, SP; Yin, FC | 1 |
| Andersson, PE; Haenni, A; Lithell, H; Reneland, R | 1 |
| Lithell, H; Reneland, R | 1 |
| Berger, R; Dukat, A; Frey, B; Hülsmann, M; Koller-Strametz, J; Kos, T; Pacher, R; Stanek, B | 1 |
| Hatzizaharias, A; Krespi, P; Kyriakidis, M; Makris, T; Triposkiadis, F; Votteas, V | 1 |
| Andersson, PE; Andrén, B; Haenni, A; Lithell, H; Reneland, R | 1 |
| Chiandussi, L; Milan, A; Morello, F; Mulatero, P; Paglieri, C; Rabbia, F; Veglio, F | 1 |
| Fomin, VV; Moiseev, SV | 1 |
| Bezruchko, BP; Gridnev, VI; Karavaev, AS; Kiselev, AR; Ponomarenko, VI; Posnenkova, OM; Prokhorov, MD | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for fosinopril and atenolol
| Article | Year |
|---|---|
[Hypertension combined with atherosclerotic lesions in carotid arteries: should angiotensin converting enzyme inhibitors be prescribed?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Antihypertensive Agents; Atenolol; Calcium Channel Blockers; Carotid Artery Diseases; Carotid Artery, Common; Chlorthalidone; Drug Therapy, Combination; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Ultrasonography; Vasodilator Agents; Verapamil | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 trial(s) available for fosinopril and atenolol
| Article | Year |
|---|---|
Different effects of fosinopril and atenolol on wave reflections in hypertensive patients.
Topics: Adult; Aged; Atenolol; Blood Pressure; Double-Blind Method; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged | 1995 |
Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Blood Pressure; Female; Fosinopril; Glucose Tolerance Test; Heart Rate; Humans; Hypertension; Insulin Resistance; Lipids; Lipoproteins; Male; Middle Aged; Peptidyl-Dipeptidase A | 1994 |
Inhibitor index: a novel method for measuring pharmacological inhibition of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Cardiology; Double-Blind Method; Female; Fluorometry; Fosinopril; Humans; Hypertension; Indoles; Male; Middle Aged; Muscle, Skeletal; Peptidyl-Dipeptidase A | 1997 |
Effects of atenolol as add-on therapy to fosinopril in heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fosinopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pilot Projects; Stroke Volume; Ventricular Function, Left | 1997 |
Insulin receptor number in arterial hypertension: response to treatment with fosinopril or atenolol.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Fosinopril; Humans; Hypertension; Male; Middle Aged; Receptor, Insulin; Reference Values; Treatment Outcome | 1998 |
Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Cross-Sectional Studies; Double-Blind Method; Feedback; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Muscle, Skeletal; Peptidyl-Dipeptidase A | 1999 |
Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Topics: Aldosterone; Amlodipine; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Confounding Factors, Epidemiologic; Diagnostic Tests, Routine; Doxazosin; False Negative Reactions; False Positive Reactions; Fosinopril; Humans; Hyperaldosteronism; Hypertension; Irbesartan; Middle Aged; Predictive Value of Tests; Renin; Renin-Angiotensin System; Sensitivity and Specificity; Tetrazoles; Tomography, X-Ray Computed | 2002 |
3 other study(ies) available for fosinopril and atenolol
| Article | Year |
|---|---|
Effects of antihypertensive treatment on cardiovascular autonomic control: a prospective study.
Topics: Antihypertensive Agents; Atenolol; Atrial Fibrillation; Autonomic Nervous System; Cohort Studies; Enalapril; Female; Fosinopril; Humans; Hypertension; Male; Metoprolol; Middle Aged; Prospective Studies | 2014 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |